Obstetrics & Gynecology Doctors in Strongsville, OH Accepting Medicare

4 Obstetrics & Gynecology doctors found. Showing 1 - 4

William K Hahn Jr., MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 18181 Pearl Rd Ste B206, Strongsville, OH 44136 Phone: 440-816-4930

Emily Allyn Lasota, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 18181 Pearl Rd Ste B206, Strongsville, OH 44136 Phone: 440-816-4930

Costas A Apostolis, M.D. Obstetrics & Gynecology - Female Pelvic Medicine and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 18181 Pearl Rd Ste B206, Strongsville, OH 44136 Phone: 440-816-4910

Johanna R O'neill, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 18181 Pearl Rd, B206, Strongsville, OH 44136 Phone: 440-816-4930

News Archive

Centura Health establishes comprehensive trauma system across its regional facilities

According to the Colorado Department of Public Health and Environment, trauma is the leading cause of death for Coloradans ages one to 44. Studies indicate that 30 to 40 percent of all trauma deaths occur within one hour of injury, and that 30 to 40 percent of these deaths are preventable if timely, appropriate care is received.

10,000th open access medical manuscript published

In a wonderful milestone for the open access publishing community BioMed Central has announced that it's 10,000th manuscript has been submitted to a BioMed Central journal.

New study on female sexuality reveals increased use of sexual aids by women

The use of sexual aids and devices is often a sensitive and embarrassing topic for women, but a new landmark study on sexual aid usage conducted by the Berman Center and funded by an unrestricted educational grant from the Sexual Well-being store may help change women's acceptance of sexual aids

Medicago completes first part of H5N1 vaccine Phase II trial

Medicago, a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that the last dose of vaccine has been administered completing the first part of the Company's Phase II human clinical trial with its H5N1 Avian Influenza vaccine.

Read more Medical News

› Verified 7 days ago